Human-Induced Pluripotent Stem Cells in Plastic and Reconstructive Surgery

被引:1
|
作者
Hadzimustafic, Nina [1 ]
D'Elia, Andrew [1 ]
Shamoun, Valentina [1 ]
Haykal, Siba [2 ]
机构
[1] Univ Toronto, Temerty Fac Med, Toronto, ON M5S 1A8, Canada
[2] Univ Hlth Network, Dept Plast & Reconstruct Surg, Toronto, ON M5G 2C4, Canada
关键词
induced pluripotent stem cells (iPSC); plastic surgery; regenerative medicine; tissue engineering; reconstructive surgery; GENERATION; DIFFERENTIATION; FIBROBLASTS; IMMUNOGENICITY; MITOCHONDRIAL; REGENERATION; INDUCTION; MOUSE; TECHNOLOGY; COMPETENT;
D O I
10.3390/ijms25031863
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A hallmark of plastic and reconstructive surgery is restoring form and function. Historically, tissue procured from healthy portions of a patient's body has been used to fill defects, but this is limited by tissue availability. Human-induced pluripotent stem cells (hiPSCs) are stem cells derived from the de-differentiation of mature somatic cells. hiPSCs are of particular interest in plastic surgery as they have the capacity to be re-differentiated into more mature cells, and cultured to grow tissues. This review aims to evaluate the applications of hiPSCs in the plastic surgery context, with a focus on recent advances and limitations. The use of hiPSCs and non-human iPSCs has been researched in the context of skin, nerve, vasculature, skeletal muscle, cartilage, and bone regeneration. hiPSCs offer a future for regenerated autologous skin grafts, flaps comprised of various tissue types, and whole functional units such as the face and limbs. Also, they can be used to model diseases affecting tissues of interest in plastic surgery, such as skin cancers, epidermolysis bullosa, and scleroderma. Tumorigenicity, immunogenicity and pragmatism still pose significant limitations. Further research is required to identify appropriate somatic origin and induction techniques to harness the epigenetic memory of hiPSCs or identify methods to manipulate epigenetic memory.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Generation of Human-Induced Pluripotent Stem Cells From Anterior Cruciate Ligament
    Woods, Steven
    Bates, Nicola
    Dunn, Sara L.
    Serracino-Inglott, Ferdinand
    Hardingham, Tim E.
    Kimber, Susan J.
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2020, 38 (01) : 92 - 104
  • [42] Influence of Nephrotoxins on the Differentiation and Dedifferentiation Processes of Human-Induced Pluripotent Stem Cells to Kidney Cells
    Johnston, I. M. Mboni
    Schupp, N.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S20 - S20
  • [43] Using Human-Induced Pluripotent Stem Cells to Model Monogenic Metabolic Disorders of the Liver
    Ordonez, Maria Paulina
    Goldstein, Lawrence S. B.
    SEMINARS IN LIVER DISEASE, 2012, 32 (04) : 298 - 306
  • [44] Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells
    Xing, Qianzhe
    Luo, Ying
    Gao, Yingtang
    Zhang, Sui
    Zhu, Zhengyan
    Wang, Yijun
    Yuan, Qiang
    Shu, Guiming
    Lou, Cheng
    Wang, Jun
    Wang, Peng
    Du, Zhi
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (08) : 731 - 737
  • [45] Directed Differentiation of Human-Induced Pluripotent Stem Cells Generates Active Motor Neurons
    Karumbayaram, Saravanan
    Novitch, Bennett G.
    Patterson, Michaela
    Umbach, Joy A.
    Richter, Laura
    Lindgren, Anne
    Conway, Anne E.
    Clark, Amander T.
    Goldman, Steve A.
    Plath, Kathrin
    Wiedau-Pazos, Martina
    Kornblum, Harley I.
    Lowry, William E.
    STEM CELLS, 2009, 27 (04) : 806 - 811
  • [46] Feasibility and application of polygenic score analysis to the morphology of human-induced pluripotent stem cells
    Coleman, Jonathan R. I.
    MOLECULAR GENETICS AND GENOMICS, 2022, 297 (04) : 1111 - 1122
  • [47] Developmental Toxicity Evaluation of Marketed Pharmaceuticals Using Human-Induced Pluripotent Stem Cells
    Turner, Katie J.
    Palmer, Jessica A.
    Thompson, Kary E.
    Rayhon, Stephanie L.
    BIRTH DEFECTS RESEARCH, 2024, 116 : S64 - S64
  • [48] Longitudinal metabolic profiling of cardiomyocytes derived from human-induced pluripotent stem cells
    Mohamed M. Bekhite
    Andrés González Delgado
    Florian Menz
    Tom Kretzschmar
    Jasmine M. F. Wu
    Tarek Bekfani
    Sandor Nietzsche
    Maria Wartenberg
    Martin Westermann
    Boris Greber
    P. Christian Schulze
    Basic Research in Cardiology, 2020, 115
  • [49] Early Senescence Is Not an Inevitable Fate of Human-Induced Pluripotent Stem-Derived Cells
    Gokoh, Maiko
    Nishio, Miwako
    Nakamura, Naoko
    Matsuyama, Satoko
    Nakahara, Masako
    Suzuki, Shinnosuke
    Mitsumoto, Masami
    Akutsu, Hidenori
    Umezawa, Akihiro
    Yasuda, Kazuki
    Yuo, Akira
    Saeki, Kumiko
    CELLULAR REPROGRAMMING, 2011, 13 (04) : 361 - 370
  • [50] In Vitro Modeling of Down Syndrome Neurogenesis Using Human-Induced Pluripotent Stem Cells
    Sharma, Vishi
    Chhawari, Harish
    Joshi, Pournima
    Nehra, Sunita
    Singhal, Nishant
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2025, (217):